Slow Capital, Inc. Editas Medicine, Inc. Transaction History

Slow Capital, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 16, 2019	SELL	$19.43 - $26.41 $277,985 - $377,847	-14,307 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$18.19 - $31.79 $31,250 - $54,615	1,718 Added 13.65%	14,307 $325,000
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $10,036 - $13,935	363 Added 2.97%	12,589 $401,000
Q2 2018 Aug 14, 2018	SELL	$31.4 - $41.01 $138,599 - $181,018	-4,414 Reduced 26.53%	12,226 $438,000
Q1 2018 May 11, 2018	BUY	$29.84 - $44.08 $8,832 - $13,047	296 Added 1.81%	16,640 $552,000
Q4 2017 Feb 15, 2018	BUY	$21.89 - $31.34 $357,770 - $512,220	16,344	16,344 $391,000

226

54.2M

412K

355K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $128M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Slow Capital, Inc. with notifications on news.